9 Meters Biopharma Inc. (NMTR)
NASDAQ: NMTR
· Real-Time Price · USD
0.07
-0.06 (-44.71%)
At close: Jul 25, 2023, 10:00 PM
9 Meters Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -46.28M | -43.77M | -41.39M | -45.58M | -42.7M | -36.78M | -32.19M | -26.98M | -63.32M |
Depreciation & Amortization | 8.22K | 8.52K | 8.9K | 8.66K | 8.09K | 7.57K | 6.26K | 12.08K | 14.32K |
Stock-Based Compensation | 3.98M | 3.94M | 3.72M | 3.52M | 2.68M | 2.41M | 2.11M | 1.78M | 4.87M |
Other Working Capital | -2.57M | -1.96M | 1.14M | 4.21M | 3.75M | 1.18M | 431.01K | 953.52K | 1.94M |
Other Non-Cash Items | 2.99M | 1.92M | 923.35K | 3.11M | 2.61M | 2.65M | 2.86M | 2.36M | 37.27M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -7K | -128.83K | -214.83K | 5.01M |
Change in Working Capital | 2.06M | 661.42K | 1.26M | 5.26M | 4.4M | 2.23M | -709.18K | -1.09M | -1.83M |
Operating Cash Flow | -37.24M | -37.24M | -35.48M | -33.68M | -33M | -29.48M | -27.93M | -23.91M | -23M |
Capital Expenditures | -2.84K | -5.68K | -5.47K | -2.5M | -2.5M | -2.51M | -2.5M | -6.89K | -5.01K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -2.42M | -2.42M | -2.42M | -2.42M | n/a | n/a |
Investing Cash Flow | -2.84K | -5.68K | -5.47K | -2.43M | -2.43M | -2.43M | -2.43M | -6.89K | -3.19M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 8.71M | 21M | 21.27M | 1.54M | 34.18M | 41.05M | 71.53M | 74.47M | 62.02M |
Financial Cash Flow | 5.45M | 17.74M | 21.27M | 1.54M | 34.18M | 41.05M | 71.53M | 74.47M | 62.02M |
Net Cash Flow | -29.62M | -17.33M | -14.21M | -34.57M | -1.25M | 9.14M | 41.17M | 50.55M | 35.83M |
Free Cash Flow | -37.25M | -37.25M | -35.48M | -36.18M | -35.51M | -31.98M | -30.43M | -23.92M | -23.01M |